New era in mass retailing about to dawn
In the aftermath of the failed Walgreens Boots Alliance Inc. (WBA) acquisition of Rite Aid Corp., very little has happened.…
August 19, 2017 by David Pinto and Chain Drug Review 2017, Issue 08-21-2017, Issues, Opinion
In the aftermath of the failed Walgreens Boots Alliance Inc. (WBA) acquisition of Rite Aid Corp., very little has happened.…
August 19, 2017 by Jeffrey Woldt and Chain Drug Review 2017, Issue 08-21-2017, Issues, Opinion
Daymond John is the quintessential entrepreneur. Most widely known for his role on ABC TV’s “Shark Tank,” he put himself…
August 19, 2017 by Sam Cinquegrani and Chain Drug Review 2017, Issue 08-21-2017, Issues, Opinion
The pharmacy that’s first to offer a seamlessly functioning, personalized voice recognition service will have a huge advantage over its…
August 17, 2017 by Stephen Ubl and Chain Drug Review Opinion
Every day at America’s community pharmacies, patients pay a bigger and bigger share of the cost for their prescription medications.…
August 16, 2017 by B. Douglas Hoey and Chain Drug Review Leading Headlines, Opinion
For many pharmacists, provider status is the Holy Grail — seemingly in range yet still agonizingly beyond their grasp. While…
August 15, 2017 by Shannon Cox, Stephen Cummings and Chain Drug Review Opinion
The United States is battling what the Centers for Disease Control and Prevention (CDC) has labeled an epidemic of prescription…
August 14, 2017 by Gregg Lipman and Chain Drug Review Featured Articles, Leading Headlines, Opinion
What would happen to your business if, tomorrow, Amazon bought a major chain like CVS Pharmacy, Walgreens or Rite Aid?…
August 8, 2017 by Dan Leonard and Chain Drug Review Opinion
Suppose two customers who are both diagnosed with rheumatoid arthritis approach your pharmacy counter. The first line of treatment for…